ABCL - Abcellera Biologics Inc.

Over the past 90 days, insiders at Abcellera Biologics Inc. (ABCL) have been net buyers, picking up 147,200 shares worth roughly $1.5M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Thermopylae Holdings Ltd.	56.13M	$683.71M	-
Dir	Michael R Hayden	1.37M	$16.73M	-
CFO	Andrew Booth	482.8K	$5.88M	-
Dir	John S. Montalbano	251.0K	$3.06M	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 3, 2021	Andrew Lo	Director	Buy	86,938	$14.02	$1,218,870.76	New	-35.5%	-9.3%
Nov 11, 2021	Andrew Booth47	Chief Financial Officer	Buy	67,500	$14.71	$993,130.00	+106.4%	-35.7%	-9.8%
Nov 11, 2021	Thermopylae Holdings Ltd.64	10% Owner	Buy	202,960	$14.76	$2,995,912.86	+0.4%	-35.7%	-9.8%
Sep 1, 2021	John Hamer	Director	Sell	300,000	$16.94	$5,082,252.98	-70.0%	-11.6%	-34.6%
Aug 16, 2021	John S. Montalbano55	Director	Buy	6,000	$17.23	$103,380.00	+30.0%	-7.2%	-27.8%
Jun 22, 2021	Michael R Hayden59	Director	Sell	100,000	$25.50	$2,550,000.00	-9.1%	-6.4%	-53.4%
Jun 9, 2021	Carl L. G. Hansen	Chief Executive Officer	Sell	6,000,000	$24.13	$144,770,322.60	-96.3%	-20.5%	-64.8%
Jun 9, 2021	Veronique Lecault48	Chief Operating Officer	Sell	1,000,000	$25.50	$25,500,000.00	-78.5%	-20.5%	-64.8%
Jun 9, 2021	Tryn Stimart	Chief Legal Officer	Sell	1,000,000	$25.50	$25,500,000.00	-100.0%	-20.5%	-64.8%
Jun 9, 2021	Ester Falconer	Chief Technology Officer	Sell	1,000,000	$25.50	$25,500,000.00	-100%	-20.5%	-64.8%